Education
About Us
Working with TipRanks
Follow Us
InMed Pharmaceuticals (DE:MWG)
FRANKFURT:MWG
| Jun 25 | Jun 24 | Jun 23 | Jun 22 | Jun 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 4.94M | $ 4.60M | $ 4.14M | $ 1.09M | $ 0.00 |
| Gross Profit | $ 1.71M | $ 1.10M | $ 1.40M | $ 543.55K | $ 0.00 |
| Operating Income | $ -7.92M | $ -8.13M | $ -8.38M | $ -13.79M | $ -12.17M |
| EBITDA | $ -7.26M | $ -7.06M | $ -7.78M | $ -13.28M | $ -12.17M |
| Net Income | $ -8.16M | $ -7.68M | $ -7.95M | $ -18.60M | $ -12.65M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 15.09M | $ 8.99M | $ 11.81M | $ 8.01M | $ 9.16M |
| Total Assets | $ 21.23M | $ 16.17M | $ 18.69M | $ 16.46M | $ 12.10M |
| Total Debt | $ 1.01M | $ 1.32M | $ 518.92K | $ 1.02M | $ 333.64K |
| Net Debt | $ -14.08M | $ -7.67M | $ -11.29M | $ -6.93M | $ -8.77M |
| Total Liabilities | $ 2.92M | $ 3.58M | $ 2.67M | $ 4.78M | $ 2.97M |
| Stockholders' Equity | $ 18.30M | $ 12.59M | $ 16.02M | $ 11.69M | $ 9.12M |
| Cash Flow | |||||
| Free Cash Flow | $ -7.77M | $ -7.00M | $ -7.45M | $ -15.62M | $ -9.79M |
| Operating Cash Flow | $ -7.77M | $ -6.99M | $ -7.28M | $ -15.58M | $ -9.79M |
| Investing Cash Flow | $ 0.00 | $ -9.29K | $ -661.80K | $ -673.00K | $ -1.73K |
| Financing Cash Flow | $ 12.27M | $ 4.65M | $ 10.68M | $ 15.07M | $ 10.85M |